Kerry Ingalls Net Worth & Insider Trades

Kerry Ingalls - Chief Operating Officer, Poseida Therapeutics, Inc

As of March 18, 2022

What is Kerry Ingalls's Net Worth?

The current estimated net worth of Poseida Therapeutics, Inc's Chief Operating Officer, Kerry Ingalls, is estimated to be about $8.76K . Kerry Ingalls owns about 55,000 units of Poseida Therapeutics, Inc common stock. In the last year at Poseida Therapeutics, Inc, Kerry Ingalls has sold an estimated value of $0 worth.

What is Kerry Ingalls's Past Insider Trading?

Kerry Ingalls's largest purchase order was 2,000 units , worth over $14K on November 18, 2021. In total, Kerry Ingalls has made about 4 transactions over a year of their time at Poseida Therapeutics, Inc. Kerry Ingalls usually trades in March, with the busiest year in 2021 and 2022. The most recent transaction was a purchase order of 3,000 units , worth over $11.94K on March 18, 2022.

Kerry Ingalls

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Kerry Ingalls's' Mailing Address?

  • Mailing address is C/o Poseida Therapeutics, Inc. 9390 Towne Centre Drive, Suite 200 San Diego CA 92121 CA

Poseida Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Eric Ostertag, M.D., Ph.D. 2020 $548,115 - $301,460 $9,102 $858,677
Eric Ostertag, M.D., Ph.D. 2019 $462,419 $2,024,600 $232,337 $8,400 $2,727,756
Mark J. Gergen, J.D. 2020 $432,680 $804,500 $194,710 $9,102 $1,440,992
Harry J. Leonhardt, J.D. 2020 $197,235 $1,720,402 $78,890 $5,401 $2,001,928
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1661460/000156459021021414/pstx-def14a_20210616.htm

What are Poseida Therapeutics, Inc's Past Insider Trades?

Poseida Therapeutics, Inc's most recent insider trade came on August 10, 2022 by Malin Life Sciences Holdings Ltd who bought 2,150,000 units worth $7.53M . In the last 2 years, insiders at Poseida Therapeutics, Inc have sold an estimated value of $8.06M and bought an estimated value of $17.61M worth of shares. Insider trading is most common in July, with the busiest year in 2021. The most active traders at the company are Eric Ostertag, Executive Chairman,  Matthew Spear, Chief Medical Officer,  and Malin Life Sciences Holdings Ltd .

Poseida Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1